Literature DB >> 315987

Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.

J Watson, S Gillis, J Marbrook, D Mochizuki, K A Smith.   

Abstract

Murine spleen cells activated by concanavalin A (Con A) in culture produce a class of lymphokine molecules which possess biological activity in a number of lymphocyte response assays. Lymphokines with a mol wt of 30,000, as estimated from gel filtration studies, can be resolved into two components which differ by charge, with isoelectric point (pI) values of 4.3 and 4.9, respectively. Both components stimulate (a) the growth of established T-cell lines in culture, (b) the proliferation of thymocytes in the presence of Con A under culture conditions where Con A alone is nonmitogenic, (c) the induction of antibody responses to heterologous erythrocyte antigens in athymic (nude) spleen cultures, (d) the generation of cytotoxic T lymphocytes (CTL) in thymocyte cultures, and (e) the generation of CTL in nude spleen cultures. In each of these culture systems we suggest that the assays are detecting a single class of lymphokine which acts directly on activated T cells. Nonactivated T cells must be stimulated by either antigen or mitogen before becoming responsive to lymphokine, but do not require antigen or mitogen for continued growth with lymphokine. The two molecular species, separable by isoelectric focusing are referred to as the T-cell growth factor (TCGF). A lymphokine, similar in size (30,000 daltons) to TCGF but heterogeneous in charge (pI 3.0--4.0), stimulates immune responses to erythrocyte antigens in T-cell-depleted spleen cultures but has no stimulatory activity in the other lymphocyte assay systems described. The data have been interpreted as showing the two molecular forms of murine TCGF (pI 4.3 and 4.9) are responsible for many of the lymphokine activities described elsewhere as thymocyte mitogenic factor, nonspecific T-cell-replacing factor and killer helper factor or costimulator. The other lymphokine, separable from TCGF by charge, appears to have true T-cell-replacing activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315987      PMCID: PMC2185677          DOI: 10.1084/jem.150.4.849

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  32 in total

1.  Molecular and quantitative analysis of helper T cell-replacing factors on the induction of antigen-sensitive B and T lymphocytes.

Authors:  J Watson; L A Aarden; J Shaw; V Paetkau
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

2.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

3.  Partial characterization and purification of murine T cell-replacing factor, TRF. II. Biochemical characteristics.

Authors:  L Hübner; G Müller; A Schimpl; E Wecker
Journal:  Immunochemistry       Date:  1978-01

4.  Activation of T and B lymphocytes in vitro. VI. Biochemical and physicochemical characterization of the allogeneic effect factor.

Authors:  D Armerding; Z Eshhar; D H Katz
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

5.  The effect of T cell growth factor on the generation of cytolytic T cells.

Authors:  P E Baker; S Gillis; M M Ferm; K A Smith
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

6.  Effects of costimulator on immune responses in vitro.

Authors:  J Shaw; V Monticone; G Mills; V Paetkau
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  Biochemical relationship between murine immune interferon and a killer cell helper factor.

Authors:  P L Simon; J J Farrar; P D Dind
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

8.  In vitro studies on H-2-linked unresponsiveness to synthetic polypeptides. III. Production of an antigen-specific T helper cell factor to (T,G)-A--L.

Authors:  S Howie; M Feldman
Journal:  Eur J Immunol       Date:  1977-07       Impact factor: 5.532

9.  A requirement for antigen-specific helper T cells in the generation of cytotoxic T cells from thymocyte precursors.

Authors:  L M Pilarski
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

10.  In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.

Authors:  S Gillis; K A Smith
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  77 in total

1.  Phosphorylation of human interleukin-2 (IL-2).

Authors:  H F Kung; I Calvert; E Bekesi; F R Khan; K P Huang; S Oroszlan; L E Henderson; T D Copeland; R C Sowder; S J Wei
Journal:  Mol Cell Biochem       Date:  1989-08-15       Impact factor: 3.396

2.  Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity.

Authors:  M Gowen; D D Wood; R G Russell
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

3.  Production and characterization of bovine interleukin-2.

Authors:  A E Namen; J A Magnuson
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

4.  Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.

Authors:  T Yamasaki; H Handa; J Yamashita; Y Watanabe; Y Namba; M Hanaoka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

5.  Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.

Authors:  P Emery; G S Panayi; A M Nouri
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

6.  Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans.

Authors:  S Gillis; R Kozak; M Durante; M E Weksler
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

7.  Interleukin-2 allows in vivo induction of anti-erythrocyte autoantibody production in nude mice associated with the injection of rat erythrocytes.

Authors:  J Reimann; T Diamantstein
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

8.  Purification and initial characterization of rat interleukin 2.

Authors:  G Di Sabato
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Cultured T lymphocytes cytotoxic for a syngeneic lymphoma: derivation in Con A-conditioned medium and in vivo activity.

Authors:  J Bertoglio; D Gerlier; J P Gerard
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

10.  Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

Authors:  M A Cheever; P D Greenberg; A Fefer; S Gillis
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.